Navigation Links
Actilyse (alteplase) Recommended by National Institute for Health,and Clinical Excellence for Treatment of Acute Ischaemic Stroke

ischaemic stroke, significantly improves clinical outcome at three months. Alteplase is an enzyme that occurs naturally in humans and causes blood clots to dissolve.

*) Actilyse® (alteplase) is registered in 85 countries across the world and marketed outside North America and Japan by Boehringer Ingelheim.

About SITS-MOST (Safe Implementation of Thrombolysis in Stroke - MOnitoring STudy)
Systematic reviews of randomised controlled trials indicate that treatment with thrombolytics is highly beneficial when given within three hours from onset of stroke symptoms. SITS-MOST, the world’s largest stroke registry/network for acute stroke centres, has demonstrated that broad implementation of thrombolysis in acute stroke treatment is both as safe and as effective in routine clinical practice as it has been shown to be in randomised clinical trials. Data from SITS-MOST (n=6483) show that ‘real-life’ treatment with Actilyse® within three hours resulted in both improved mortality (11.3% vs. 17.3%) and safety (symptomatic intracerebral haemorrhage 7.3% vs. 8.6%) when compared to randomised controlled trials.2

SITS-MOST is embedded within the Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Register (SITS-ISTR), an internet-based, international monitoring registry for auditing the safety and efficacy of routine therapeutic use of thrombolysis in acute ischaemic stroke. The registry is available to clinicians in many countries worldwide except Japan and North America. Acute stroke treatment with thrombolysis is currently under-used with wide variations from country to country and region to region. Less than two percent of overall stroke patients in the EU currently receive thrombolysis.

About ECASS III
The objective of the ECASS III study is to evaluate the efficacy and safety of intravenous thrombolysis using Actilyse® in patients with acute ischaemic stroke and confirm that the
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
2. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
3. Positive Results Prompt US National Cancer Institute to Make Glivec Available to Patients in Post-Surgical GIST Study
4. Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical Gist Study
5. First-of-its-Kind National Report Reveals Estimated High Prevalence and Heavy Cost of Type 2 Diabetes Complications in America
6. Research Results on FluMist Presented at National Association of Pediatric Nurse Practitioners Conference
7. Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases
8. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
9. Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings
10. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
11. Southern Research Institute to Present at the 2007 American Association For Cancer Research Annual Meeting
Post Your Comments:
(Date:7/6/2015)... FARMINGTON, Conn. , July 6, 2015 /PRNewswire/ ... company developing targeted, receptor-specific peptide therapeutics for the ... and commercial potential, today announced that it has ... warrants to purchase 21,917,808 shares of its common ... shares of its common stock.  Certain funds managed ...
(Date:7/6/2015)... , July 6, 2015   Cepheid (Nasdaq: ... results for its 2015 second quarter ended June 30, ... of the market. The Company will host ... Thursday, July 23, 2015, to discuss the results.  To ... http://ir.cepheid.com at least 15 minutes before the ...
(Date:7/6/2015)... , July 6, 2015 /PRNewswire/ -- China Nepstar Chain ... "Company"), a leading retail drugstore chain in ... operated stores, today announced that its board of directors ... 6, 2015, from Simin Zhang , chairman of ... Neptunus Drugstore Holding Ltd., an investment vehicle wholly owned ...
Breaking Medicine Technology:Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 2China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 3China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 4China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 5China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal 6
... Calif., Oct. 7 Onyx Pharmaceuticals, Inc. (Nasdaq: ... its New Drug Application (NDA) filing for carfilzomib based ... Controls (CMC) review division of the U.S. Food and ... information related to commercial-scale manufacturing of carfilzomib.  Onyx had ...
... NEW YORK, Oct. 7 Reportlinker.com announces that a ... European RIS/PACS Market ... European RIS/PACS market in terms of the challenges faced ... The main chapters of the research service include an ...
Cached Medicine Technology:Onyx Pharmaceuticals Provides Status Update on Carfilzomib 2Onyx Pharmaceuticals Provides Status Update on Carfilzomib 3Reportlinker Adds European RIS/PACS Market 2Reportlinker Adds European RIS/PACS Market 3
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... MD Now, ... Monday, July 6. The newly constructed urgent care center will serve residents and visitors ... In addition to being MD Now’s 22nd South Florida location, the new facility will ...
(Date:7/6/2015)... ... July 06, 2015 , ... World renowned Los Angeles facial plastic ... ideal appearance through comprehensive treatment solutions. Individuals that want to make multiple changes to ... a plan that resolves each of their needs. , "Anytime I see an ...
(Date:7/6/2015)... , ... July 06, 2015 , ... Diabetes affects many ... More than 29 million Americans have diabetes, the majority of which are Type 2. ... adults or more than one in three, have prediabetes (abnormally high blood sugar levels). ...
(Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based specialty ... co-produce two training clinics for first-time triathletes this summer with ethos, the owner and ... on Thursday, July 9, at 6:00 p.m. at the North End Greenway. The event ...
(Date:7/5/2015)... ... ... Doctors at the Swedish Cancer Institute in Seattle, Washington say with careful ... for people with pleural mesothelioma. Surviving Mesothelioma has just posted the full story. ... patients treated with 25Gy of radiation over five days just prior to surgery had ...
Breaking Medicine News(10 mins):Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2
... corpses, cancerous mouths and the caption 'your smoking kills ... from// June to dissuade people from consuming them, Health ... said the current warning, "cigarette smoking is injurious to ... would help the cause better. ,All tobacco ...
... Ministry of Health (MoH), United Arab Emirates has revealed 645 ... country//, media reported Wednesday. ,"Only a few cases ... increasing significantly," Ali Shukur, Under-secretary of the Ministry of Health ... social stigma attached to the fatal transmissible disorder was impeding ...
... was thought to remedy eyesight problems, an extension of the ... being good for eyesight. A novel research has suggested that ... improving age associated macular degeneration. Age related macular degeneration is ... vision loss. ,It might seem like a ...
... out with findings that suggest that programs to help the ... till further study. , The researchers led by ... medicine at Sydney’s Concord Hospital, examined more than 600 people ... surgery. They found that these elders were ...
... study as a ‘springboard for developing new and better ways ... that// show fat men to be jolly. ,Lead ... Boston has discovered a link between men with higher body ... This finding, published in the Archives of Internal Medicine, ...
... new study finds that zolpidem, temporarily improved brain function in ... to communicate// , walk, and eat without assistance after receiving ... ,Zolpidem is a drug normally used to treat insomnia.,Akinetic mutism ... cannot speak or move. ,The study was ...
Cached Medicine News:Health News:Zolpidem Might Assist Patients With Akinetic Mutism 2
... the HI VISION 8500 diagnostic ultrasound ... user-oriented operation for exceptional imaging and ... consists of advanced techniques for image ... multi-angle spatial compounding, wideband pulse-inversion, tissue ...
... EG-3630U incorporates a 2.4mm channel within a ... all electronic convex linear array ultrasound image ... for improved lateral resolution, and a 7.5 ... The color & pulsed doppler allows ...
... The advanced features of the ELECTRA ... operational costs with extended walkaway capabilities. This ... performs APTT, PT, fibrinogen and factor assays ... an integrated barcode reader and automatic preparation ...
... ACL 7000 coagulation analyzer is the ... needs a full range of testing ... have access to a broad test ... Plus, you'll benefit from an easy-to-use, ...
Medicine Products: